Atrial fibrillation in primary aldosteronism
- PMID: 19617274
- DOI: 10.1177/1470320309342734
Atrial fibrillation in primary aldosteronism
Abstract
Introduction: Primary aldosteronism (PA) is caused by autonomous hypersecretion of aldosterone from the adrenal cortex, classically from an adenoma, resulting in sodium and water retention, hypokalaemia and raised blood pressure. The sodium and water retention causes suppression of renin release. The possible cardiac sequelae of aldosterone excess are encountered primarily in patients with secondary hyperaldosteronism due to heart failure, where plasma renin, angiotensin and aldosterone levels are all raised. However, there is also evidence that primary aldosterone excess, in the presence of low renin levels, may also be cardiotoxic.
Patients: In this report, we describe five patients with PA, who developed atrial fibrillation (AF) in the absence of structural cardiac lesions and in one case despite good control of blood pressure and electrolytes.
Conclusion: In patients with hypertension and AF, who have no evidence of coronary disease or any other underlying cause of AF with preserved systolic function, a diagnosis of PA should be considered.
Similar articles
-
The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.Kardiol Pol. 2003 Jan;58(1):17-26. Kardiol Pol. 2003. PMID: 14502298
-
Normokalemic hyperaldosteronism in patients with resistant hypertension.Isr Med Assoc J. 2002 Jan;4(1):17-20. Isr Med Assoc J. 2002. PMID: 11802302
-
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8. doi: 10.1016/j.jacc.2005.01.015. J Am Coll Cardiol. 2005. PMID: 15837256 Clinical Trial.
-
Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x. Clin Endocrinol (Oxf). 2007. PMID: 17492946 Review.
-
Primary aldosteronism, a common entity? the myth persists.J Hum Hypertens. 2002 Mar;16(3):159-62. doi: 10.1038/sj.jhh.1001321. J Hum Hypertens. 2002. PMID: 11896504 Review.
Cited by
-
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.Hypertension. 2017 Apr;69(4):545-550. doi: 10.1161/HYPERTENSIONAHA.116.08956. Hypertension. 2017. PMID: 28264920 Free PMC article. Review. No abstract available.
-
Thrombin Induces Angiotensin II-Mediated Senescence in Atrial Endothelial Cells: Impact on Pro-Remodeling Patterns.J Clin Med. 2019 Oct 1;8(10):1570. doi: 10.3390/jcm8101570. J Clin Med. 2019. PMID: 31581517 Free PMC article.
-
Aldosterone Effect on Cardiac Structure and Function.Curr Cardiol Rev. 2024;20(4):e290224227534. doi: 10.2174/011573403X281390240219063817. Curr Cardiol Rev. 2024. PMID: 38425104 Free PMC article. Review.
-
Primary Aldosteronism and Cerebrovascular Diseases.Endocrinol Metab (Seoul). 2018 Dec;33(4):429-434. doi: 10.3803/EnM.2018.33.4.429. Endocrinol Metab (Seoul). 2018. PMID: 30513556 Free PMC article. Review.
-
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.J Hum Hypertens. 2023 Sep;37(9):757-766. doi: 10.1038/s41371-022-00753-2. Epub 2022 Sep 24. J Hum Hypertens. 2023. PMID: 36153382
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical